Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-143310
Filing Date
2018-04-30
Accepted
2018-04-30 16:31:56
Documents
4
Period of Report
2018-06-25
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d535515ddef14a.htm DEF 14A 451043
2 GRAPHIC g535515g79v64.jpg GRAPHIC 36758
3 GRAPHIC g535515i1.jpg GRAPHIC 203723
4 GRAPHIC g535515i2.jpg GRAPHIC 202215
  Complete submission text file 0001193125-18-143310.txt   1062214
Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36829 | Film No.: 18790305
SIC: 2834 Pharmaceutical Preparations